While other MediaPost newsletters and articles remain free to all ... our new Research Intelligencer service is reserved for paid subscribers ...
Subscribe today to gain access to every Research Intelligencer article we publish as well as the exclusive daily newsletter, full access to The MediaPost Cases, first-look research and daily insights from Joe Mandese, Editor in Chief.
Bad actors are bypassing spam filters, using a new technique when promoting purported pharmaceutical products. The new technique relies on unconventional representation of URLs to remain
undetected.